News for Fluidigm Corporation (FLDM)

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein P

Standard BioTools focuses on proteomics innovation with cost-cutting efforts, aiming for profitability amid macro challenges.

Featuring top researchers and industry experts using high-throughput proteomics to drive breakthroughs in population health, translational research and clinica

**media[641262]**

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ( LAB) (the ”œCompany” or ”œStandard BioTools”) today announced fin

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. ( SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on

**media[602242]**

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ( LAB) today announced that company management will participate in the f

**media[552834]**

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ( LAB) (the ”œCompany” or ”œStandard BioTools”) today announced fi

**media[551520]**

Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thu

**media[509161]**

**media[496616]**

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cancer Cell Analysis...

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024...

A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...

The time has finally come! The most pivotal earnings report for the entire stock market, the emotional leader of all investments, and the vanguard of the AI r...

Casdin Partners master fund buys Standard Biotools shares worth over $546k